Abstract
Chemical synthesis of small molecules is well established and enzyme-mediated chemical synthesis is a growing area, with great potential to be expanded in the future. The recombinant production of proteins has become routine. But molecules of intermediate size remain generally much more difficult to be produced in a sustainable way. Oligopeptides, oligosaccharides and oligonucleotides are three areas orphaned by biotechnology. The industrial manufacturing of all three oligomer types uses almost exclusively chemical synthesis, although conceptually biotechnological methods exist. This review gives an introduction to the market and applications of all three product classes as well as manufacturing options. The future situation could become difficult for all three, but particularly rapidly for peptides, where a number of products are discussed for markets other than the parenteral (injectable) pharmaceuticals. Cost and e-factors of actual chemical methods are by far too high to allow such commercial application, and ecologically and economically sustainable manufacturing methods are urgently needed. The review also shows that similar problems may arise for future pharmaceutical oligonucleotide and oligosaccharide drug products, as aspects of sustainability and cost of goods may significantly limit their broad availability and thereby their potential for commercial success.
Keywords: Applications, biotechnology, chemistry, fermentation, markets, oligonucleotides, oligosaccharides, peptides, recombinant organisms, sustainability.
Current Organic Chemistry
Title:Bridging the Gap Between Chemistry and Biotechnology - Large Molecules with Potential, How Could Biotechnology Complement Chemistry?
Volume: 18 Issue: 8
Author(s): Hans-Peter Meyer, Oleg Werbitzky and Gian A. Signorell
Affiliation:
Keywords: Applications, biotechnology, chemistry, fermentation, markets, oligonucleotides, oligosaccharides, peptides, recombinant organisms, sustainability.
Abstract: Chemical synthesis of small molecules is well established and enzyme-mediated chemical synthesis is a growing area, with great potential to be expanded in the future. The recombinant production of proteins has become routine. But molecules of intermediate size remain generally much more difficult to be produced in a sustainable way. Oligopeptides, oligosaccharides and oligonucleotides are three areas orphaned by biotechnology. The industrial manufacturing of all three oligomer types uses almost exclusively chemical synthesis, although conceptually biotechnological methods exist. This review gives an introduction to the market and applications of all three product classes as well as manufacturing options. The future situation could become difficult for all three, but particularly rapidly for peptides, where a number of products are discussed for markets other than the parenteral (injectable) pharmaceuticals. Cost and e-factors of actual chemical methods are by far too high to allow such commercial application, and ecologically and economically sustainable manufacturing methods are urgently needed. The review also shows that similar problems may arise for future pharmaceutical oligonucleotide and oligosaccharide drug products, as aspects of sustainability and cost of goods may significantly limit their broad availability and thereby their potential for commercial success.
Export Options
About this article
Cite this article as:
Meyer Hans-Peter, Werbitzky Oleg and Signorell A. Gian, Bridging the Gap Between Chemistry and Biotechnology - Large Molecules with Potential, How Could Biotechnology Complement Chemistry?, Current Organic Chemistry 2014; 18 (8) . https://dx.doi.org/10.2174/138527281808140616154443
DOI https://dx.doi.org/10.2174/138527281808140616154443 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)
Current Vascular Pharmacology Adverse Drug Reactions in a Pulmonary Teaching Hospital: Incidence, Pattern, Seriousness, and Preventability
Current Drug Safety Complement and Complement Regulatory Proteins as Potential Molecular Targets for Vascular Diseases
Current Pharmaceutical Design Metal Allergens of Growing Significance: Epidemiology, Immunotoxicology, Strategies for Testing and Prevention
Inflammation & Allergy - Drug Targets (Discontinued) Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Current Vascular Pharmacology Cutaneous Adverse Reactions to Amoxicillin-Clavulanic Acid Suspension in Children: The Role of Sodium Benzoate
Current Drug Safety Adverse Effects and Drug Interactions of Biologic Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Factors Associated with Self-Reported Drug Allergies in a Large Chronic Spontaneous Urticaria Cohort
Current Drug Safety Pharmacological, Immunological, and Gene Targeting of the Renin-Angiotensin System for Treatment of Cardiovascular Disease
Current Pharmaceutical Design Ventricular Arrhythmias in Seniors with Heart Failure: Present Dilemmas and Therapeutic Considerations: A Systematic Review
Current Cardiology Reviews Prevalence of Intestinal Parasites among Patients with Chronic Urticaria in Northern Iran
Infectious Disorders - Drug Targets Skin Allergy to Azole Antifungal Agents for Systemic Use: A Review of the Literature
Recent Patents on Inflammation & Allergy Drug Discovery Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol
Current Vascular Pharmacology Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders
Current Drug Metabolism Current and Future Chemotherapy for Chagas Disease
Current Medicinal Chemistry Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk
Current Vascular Pharmacology Serum Sickness Reaction to Rituximab with Positive Immediate Intradermal Skin Test: A Case Report
New Emirates Medical Journal Editorial [Hot topic: Recent Progress in Cancer Therapeutics (Guest Editor: Kurt S. Zaenker)]
Current Molecular Medicine Patent Annotations
Recent Patents on Cardiovascular Drug Discovery